Towards subtlety: Understanding the role of Toll-like receptor signaling in susceptibility to human infections

Clinical Immunology

Volumn 120, Issue 1, 2006, Pages 1-9

  Turvey, Stuart E ^a   Hawn, Thomas R ^b  

^a BC CHILDREN S HOSPITAL   (Canada)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical immunodeficiency; Genetic variation; Innate immunity; Toll like receptor signaling

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; UNCLASSIFIED DRUG;

ANHIDROSIS; AUTOSOMAL DOMINANT DISORDER; DISEASE PREDISPOSITION; ECTODERMAL DYSPLASIA; ENZYME DEFICIENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HOST; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; INFECTION; INNATE IMMUNITY; MICROORGANISM; MONOGENIC DISORDER; PATIENT CARE; PRIORITY JOURNAL; SHORT SURVEY;

DISEASE SUSCEPTIBILITY; HUMANS; IMMUNITY, NATURAL; INFECTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 33745174546     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.02.003     Document Type: Short Survey

References (74)

1. Casanova J.L., Fieschi C., Bustamante J., Reichenbach J., Remus N., von Bernuth H., and Picard C. From idiopathic infectious diseases to novel primary immunodeficiencies. J. Allergy Clin. Immunol. 116 (2005) 426-430
2. Bruton O.C. Agammaglobulinemia. Pediatrics 9 (1952) 722-728
3. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20 (2002) 197-216
4. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., and Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86 (1996) 973-983
5. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu. Rev. Immunol. 21 (2003) 335-376
6. Koedel U., Angele B., Rupprecht T., Wagner H., Roggenkamp A., Pfister H.W., and Kirschning C.J. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J. Immunol. 170 (2003) 438-444
7. Yoshimura A., Lien E., Ingalls R.R., Tuomanen E., Dziarski R., and Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163 (1999) 1-5
8. Knapp S., Wieland C.W., van 't Veer C., Takeuchi O., Akira S., Florquin S., and van der Poll T. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J. Immunol. 172 (2004) 3132-3138
9. Malley R., Henneke P., Morse S.C., Cieslewicz M.J., Lipsitch M., Thompson C.M., Kurt-Jones E., Paton J.C., Wessels M.R., and Golenbock D.T. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1966-1971
10. Schroder N.W., Morath S., Alexander C., Hamann L., Hartung T., Zahringer U., Gobel U.B., Weber J.R., and Schumann R.R. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 278 (2003) 15587-15594
11. Srivastava A., Henneke P., Visintin A., Morse S.C., Martin V., Watkins C., Paton J.C., Wessels M.R., Golenbock D.T., and Malley R. The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease. Infect. Immun. 73 (2005) 6479-6487
12. Akira S., and Takeda K. Toll-like receptor signalling. Nat. Rev., Immunol. 4 (2004) 499-511
13. Takeda K., and Akira S. TLR signaling pathways. Semin. Immunol. 16 (2004) 3-9
14. Zonana J., Elder M.E., Schneider L.C., Orlow S.J., Moss C., Golabi M., Shapira S.K., Farndon P.A., Wara D.W., Emmal S.A., and Ferguson B.M. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am. J. Hum. Genet. 67 (2000) 1555-1562
15. Mansour S., Woffendin H., Mitton S., Jeffery I., Jakins T., Kenwrick S., and Murday V.A. Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection. Am. J. Med. Genet. 99 (2001) 172-177
16. Doffinger R., Smahi A., Bessia C., Geissmann F., Feinberg J., Durandy A., Bodemer C., Kenwrick S., Dupuis-Girod S., Blanche S., Wood P., Rabia S.H., Headon D.J., Overbeek P.A., Le Deist F., Holland S.M., Belani K., Kumararatne D.S., Fischer A., Shapiro R., Conley M.E., Reimund E., Kalhoff H., Abinun M., Munnich A., Israel A., Courtois G., and Casanova J.L. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat. Genet. 27 (2001) 277-285
17. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 (2002) S81-S96 (Suppl.)
18. Teitelbaum S.L., and Ross F.P. Genetic regulation of osteoclast development and function. Nat. Rev., Genet. 4 (2003) 638-649
19. Orange J.S., Levy O., Brodeur S.R., Krzewski K., Roy R.M., Niemela J.E., Fleisher T.A., Bonilla F.A., and Geha R.S. Human nuclear factor kappaB essential modulator mutation can result in immunodeficiency without ectodermal dysplasia. J. Allergy Clin. Immunol. 114 (2004) 650-656
20. Niehues T., Reichenbach J., Neubert J., Gudowius S., Puel A., Horneff G., Lainka E., Dirksen U., Schroten H., Doffinger R., Casanova J.L., and Wahn V. Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia. J. Allergy Clin. Immunol. 114 (2004) 1456-1462
21. Carrol E.D., Gennery A.R., Flood T.J., Spickett G.P., and Abinun M. Anhidrotic ectodermal dysplasia and immunodeficiency: the role of NEMO. Arch. Dis. Child. 88 (2003) 340-341
22. Dupuis-Girod S., Corradini N., Hadj-Rabia S., Fournet J.C., Faivre L., Le Deist F., Durand P., Doffinger R., Smahi A., Israel A., Courtois G., Brousse N., Blanche S., Munnich A., Fischer A., Casanova J.L., and Bodemer C. Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother. Pediatrics 109 (2002) e97
23. Orange J.S., Jain A., Ballas Z.K., Schneider L.C., Geha R.S., and Bonilla F.A. The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. J. Allergy Clin. Immunol. 113 (2004) 725-733
24. Courtois G., Smahi A., Reichenbach J., Doffinger R., Cancrini C., Bonnet M., Puel A., Chable-Bessia C., Yamaoka S., Feinberg J., Dupuis-Girod S., Bodemer C., Livadiotti S., Novelli F., Rossi P., Fischer A., Israel A., Munnich A., Le Deist F., and Casanova J.L. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J. Clin. Invest. 112 (2003) 1108-1115
25. Chapel H., Puel A., von Bernuth H., Picard C., and Casanova J.L. Shigella sonnei meningitis due to interleukin-1 receptor-associated kinase-4 deficiency: first association with a primary immune deficiency. Clin. Infect. Dis. 40 (2005) 1227-1231
26. Currie A.J., Davidson D.J., Reid G.S., Bharya S., MacDonald K.L., Devon R.S., and Speert D.P. Primary immunodeficiency to pneumococcal infection due to a defect in Toll-like receptor signaling. J. Pediatr. 144 (2004) 512-518
27. Medvedev A.E., Lentschat A., Kuhns D.B., Blanco J.C., Salkowski C., Zhang S., Arditi M., Gallin J.I., and Vogel S.N. Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J. Exp. Med. 198 (2003) 521-531
28. Picard C., Puel A., Bonnet M., Ku C.L., Bustamante J., Yang K., Soudais C., Dupuis S., Feinberg J., Fieschi C., Elbim C., Hitchcock R., Lammas D., Davies G., Al-Ghonaium A., Al-Rayes H., Al-Jumaah S., Al-Hajjar S., Al-Mohsen I.Z., Frayha H.H., Rucker R., Hawn T.R., Aderem A., Tufenkeji H., Haraguchi S., Day N.K., Good R.A., Gougerot-Pocidalo M.A., Ozinsky A., and Casanova J.L. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299 (2003) 2076-2079
29. Enders A., Pannicke U., Berner R., Henneke P., Radlinger K., Schwarz K., and Ehl S. Two siblings with lethal pneumococcal meningitis in a family with a mutation in Interleukin-1 receptor-associated kinase 4. J. Pediatr. 145 (2004) 698-700
30. Day N., Tangsinmankong N., Ochs H., Rucker R., Picard C., Casanova J.L., Haraguchi S., and Good R. Interleukin receptor-associated kinase (IRAK-4) deficiency associated with bacterial infections and failure to sustain antibody responses. J. Pediatr. 144 (2004) 524-526
31. Yang K., Puel A., Zhang S., Eidenschenk C., Ku C.L., Casrouge A., Picard C., von Bernuth H., Senechal B., Plancoulaine S., Al-Hajjar S., Al-Ghonaium A., Marodi L., Davidson D., Speert D., Roifman C., Garty B.Z., Ozinsky A., Barrat F.J., Coffman R.L., Miller R.L., Li X., Lebon P., Rodriguez-Gallego C., Chapel H., Geissmann F., Jouanguy E., and Casanova J.L. Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity 23 (2005) 465-478
32. Puel A., Picard C., Ku C.L., Smahi A., and Casanova J.L. Inherited disorders of NF-kappaB-mediated immunity in man. Curr. Opin. Immunol. 16 (2004) 34-41
33. Sorensen T.I., Nielsen G.G., Andersen P.K., and Teasdale T.W. Genetic and environmental influences on premature death in adult adoptees. N. Engl. J. Med. 318 (1988) 727-732
34. Notarangelo L., Casanova J.L., Fischer A., Puck J., Rosen F., Seger R., and Geha R. Primary immunodeficiency diseases: an update. J. Allergy Clin. Immunol. 114 (2004) 677-687
35. Goldstein D.B., and Cavalleri G.L. Genomics: understanding human diversity. Nature 437 (2005) 1241-1242
36. Cooke G.S., and Hill A.V. Genetics of susceptibility to human infectious disease. Nat. Rev., Genet. 2 (2001) 967-977
37. Schork N.J., Fallin D., and Lanchbury J.S. Single nucleotide polymorphisms and the future of genetic epidemiology. Clin. Genet. 58 (2000) 250-264
38. Frodsham A.J., and Hill A.V. Genetics of infectious diseases. Hum. Mol. Genet. 13 (2004) R187-R194 (Spec No. 2)
39. Segal S., and Hill A.V. Genetic susceptibility to infectious disease. Trends Microbiol. 11 (2003) 445-448
40. Hill A.V. The genomics and genetics of human infectious disease susceptibility. Annu. Rev. Genomics Hum. Genet. 2 (2001) 373-400
41. Roy S., Knox K., Segal S., Griffiths D., Moore C.E., Welsh K.I., Smarason A., Day N.P., McPheat W.L., Crook D.W., and Hill A.V. MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet 359 (2002) 1569-1573
42. Yee A.M., Phan H.M., Zuniga R., Salmon J.E., and Musher D.M. Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia. Clin. Infect. Dis. 30 (2000) 25-28
43. Rosenberg R.N. Translational research on the way to effective therapy for Alzheimer disease. Arch. Gen. Psychiatry 62 (2005) 1186-1192
44. Shaheen F., and Collman R.G. Co-receptor antagonists as HIV-1 entry inhibitors. Curr. Opin. Infect. Dis. 17 (2004) 7-16
45. Yee L.J., Tang J., Gibson A.W., Kimberly R., Van Leeuwen D.J., and Kaslow R.A. Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology 33 (2001) 708-712
46. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5 (2004) 987-995
47. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., Frees K., Watt J.L., and Schwartz D.A. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25 (2000) 187-191
48. Erridge C., Stewart J., and Poxton I.R. Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. J. Exp. Med. 197 (2003) 1787-1791
49. von Aulock S., Schroder N.W., Gueinzius K., Traub S., Hoffmann S., Graf K., Dimmeler S., Hartung T., Schumann R.R., and Hermann C. Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood. J. Infect. Dis. 188 (2003) 938-943
50. Lorenz E., Mira J.P., Frees K.L., and Schwartz D.A. Relevance of mutations in the TLR4 receptor in patients with Gram-negative septic shock. Arch. Intern. Med. 162 (2002) 1028-1032
51. Agnese D.M., Calvano J.E., Hahm S.J., Coyle S.M., Corbett S.A., Calvano S.E., and Lowry S.F. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of Gram-negative infections. J. Infect. Dis. 186 (2002) 1522-1525
52. Smirnova I., Mann N., Dols A., Derkx H.H., Hibberd M.L., Levin M., and Beutler B. Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 6075-6080
53. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., Walsh E.E., Freeman M.W., Golenbock D.T., Anderson L.J., and Finberg R.W. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1 (2000) 398-401
54. Tal G., Mandelberg A., Dalal I., Cesar K., Somekh E., Tal A., Oron A., Itskovich S., Ballin A., Houri S., Beigelman A., Lider O., Rechavi G., and Amariglio N. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J. Infect. Dis. 189 (2004) 2057-2063
55. Hawn T.R., Verbon A., Janer M., Zhao L.P., Beutler B., and Aderem A. Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2487-2489
56. Girard R., Pedron T., Uematsu S., Balloy V., Chignard M., Akira S., and Chaby R. Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via Toll-like receptor 2. J. Cell Sci. 116 (2003) 293-302
57. Cooke G.S., Segal S., and Hill A.V. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347 (2002) 1978-1980 (author reply 1978-1980)
58. Read R.C., Pullin J., Gregory S., Borrow R., Kaczmarski E.B., di Giovine F.S., Dower S.K., Cannings C., and Wilson A.G. A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J. Infect. Dis. 184 (2001) 640-642
59. Ogus A.C., Yoldas B., Ozdemir T., Uguz A., Olcen S., Keser I., Coskun M., Cilli A., and Yegin O. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur. Respir. J. 23 (2004) 219-223
60. Schroder N.W., Diterich I., Zinke A., Eckert J., Draing C., von Baehr V., Hassler D., Priem S., Hahn K., Michelsen K.S., Hartung T., Burmester G.R., Gobel U.B., Hermann C., and Schumann R.R. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J. Immunol. 175 (2005) 2534-2540
61. Moore C.E., Segal S., Berendt A.R., Hill A.V., and Day N.P. Lack of association between Toll-like receptor 2 polymorphisms and susceptibility to severe disease caused by Staphylococcus aureus. Clin. Diagn. Lab. Immunol. 11 (2004) 1194-1197
62. Yim J.J., Lee H.W., Lee H.S., Kim Y.W., Han S.K., Shim Y.S., and Holland S.M. The association between microsatellite polymorphisms in intron II of the human Toll-like receptor 2 gene and tuberculosis among Koreans. Genes Immun. (2006) 150-155
63. Kang T.J., and Chae G.T. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol. Med. Microbiol. 31 (2001) 53-58
64. Ben-Ali M., Barbouche M.R., Bousnina S., Chabbou A., and Dellagi K. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin. Diagn. Lab. Immunol. 11 (2004) 625-626
65. Malhotra D., Relhan V., Reddy B.S., and Bamezai R. TLR2 Arg677Trp polymorphism in leprosy: revisited. Hum. Genet. 116 (2005) 413-415
66. Hawn T.R., Verbon A., Lettinga K.D., Zhao L.P., Li S.S., Laws R.J., Skerrett S.J., Beutler B., Schroeder L., Nachman A., Ozinsky A., Smith K.D., and Aderem A. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J. Exp. Med. 198 (2003) 1563-1572
67. Dunstan S.J., Hawn T.R., Hue N.T., Parry C.P., Ho V.A., Vinh H., Diep T.S., House D., Wain J., Aderem A., Hien T.T., and Farrar J.J. Host susceptibility and clinical outcomes in toll-like receptor 5-deficient patients with typhoid fever in Vietnam. J. Infect. Dis. 191 (2005) 1068-1071
68. Feterowski C., Emmanuilidis K., Miethke T., Gerauer K., Rump M., Ulm K., Holzmann B., and Weighardt H. Effects of functional Toll-like receptor-4 mutations on the immune response to human and experimental sepsis. Immunology 109 (2003) 426-431
69. Faber J., Meyer C.U., Gemmer C., Russo A., Finn A., Murdoch C., Zenz W., Mannhalter C., Zabel B.U., Schmitt H.J., Habermehl P., Zepp F., and Knuf M. Human toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy. Pediatr. Infect. Dis. J. 25 (2006) 80-81
70. Lorenz E., Mira J.P., Cornish K.L., Arbour N.C., and Schwartz D.A. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect. Immun. 68 (2000) 6398-6401
71. Allen A., Obaro S., Bojang K., Awomoyi A.A., Greenwood B.M., Whittle H., Sirugo G., and Newport M.J. Variation in Toll-like receptor 4 and susceptibility to group A meningococcal meningitis in Gambian children. Pediatr. Infect. Dis. J. 22 (2003) 1018-1019
72. Mockenhaupt F.P., Cramer J.P., Hamann L., Stegemann M.S., Eckert J., Oh N.R., Otchwemah R.N., Dietz E., Ehrhardt S., Schroder N.W., Bienzle U., and Schumann R.R. Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 177-182
73. Newport M.J., Allen A., Awomoyi A.A., Dunstan S.J., McKinney E., Marchant A., and Sirugo G. The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia. Tuberculosis (Edinb) 84 (2004) 347-352
74. Rezazadeh M., Hajilooi M., Rafiei A., Haidari M., Nikoopour E., Kerammat F., Mamani M., Ranjbar M., and Hashemi H. TLR4 polymorphism in Iranian patients with brucellosis. J. Infect. (2005) (electronic publication ahead of print)